Vir Biotechnology
Vir Biotechnology
Immunology-focused biotech
Drug Discovery
Immunology
Infectious Diseases
Clinical Research
Bioinformatics
Open roles at Vir Biotechnology
10 open roles
Vice President, Head of Biometrics
Data Science
San Francisco, California, United States
Hybrid
Vp
Full-time
401(k)
Equity
Performance Bonus
Paid Time Off
1 week ago
Scientist, Analytical Development Bioassays (Temporary)
Healthcare
San Francisco, California, United States
On-site
Senior
Temporary
Learning Budget
1 week ago
Associate Director, Medical Affairs Operations
Healthcare
San Francisco, California, United States
Hybrid
Director
Full-time
401(k)
Equity
Performance Bonus
Paid Time Off
1 week ago
Senior Director, Clinical Research-Oncology
Healthcare
San Francisco, California, United States
On-site
Director
Full-time
401(k)
Equity
Performance Bonus
Paid Time Off
2 months ago
Director, Translational Biology
Machine Learning
San Francisco, California, United States
On-site
Director
Full-time
2 months ago
Senior Director, Organizational Design
HR
San Francisco, California, United States
On-site
Director
Full-time
401(k)
Equity
Performance Bonus
Paid Time Off
2 months ago
Vice President, Strategy and Portfolio Planning
Product
San Francisco, California, United States
On-site
Executive
Full-time
Paid Time Off
Equity
3 months ago
Senior Director, Clinical Pharmacology and Translational PK/PD
Healthcare
San Francisco, California, United States
On-site
Director
Full-time
Paid Time Off
Equity
3 months ago
Senior Director, Alliance Management
Business Development
San Francisco, California, United States
On-site
Director
Full-time
Paid Time Off
Equity
3 months ago
SVP, Oncology Therapeutic Area Head
Healthcare
San Francisco, California, United States
On-site
Vp
Full-time
Paid Time Off
Equity
3 months ago
Closed positions
49 positions
SVP, Oncology Therapeutic Area Head
San Francisco, California, United States
Vp
Closed 1 week ago
Vice President, Head of Biometrics
San Francisco, California, United States
Vp
Closed 1 week ago
Scientist, Analytical Development Bioassays (Temporary)
San Francisco, California, United States
Senior
Closed 1 week ago
Director, CMC Regulatory Affairs
San Francisco, California, United States
Director
Closed 1 week ago
Vice President, Strategy and Portfolio Planning
San Francisco, California, United States
Executive
Closed 1 week ago
Products and services
Tobevibart and Elebsiran Combination Therapy for Chronic Hepatitis Delta
Antiviral Therapeutics
VI
VIR-2218
Antiviral Therapy
VI
VIR-3434
Monoclonal Antibody
VI
VIR-7831 (Sotrovimab)
Monoclonal Antibody
EL
Elebsiran (VIR-2218)
Antiviral Therapy
PRO-XTEN™ Masked T-cell Engagers for Oncology
Immuno-Oncology
PL
Platform Technologies
Technology Platform
CO
COVID-19 Variant Antibodies
Monoclonal Antibody
SO
Sotrovimab
Antiviral Therapy
HI
HIV Cure Research
Antiviral Therapy
VI
VIR-7229
Antiviral Therapy
MA
Malaria Prevention Program
Monoclonal Antibody
VI
VIR-2482
Antiviral Therapy
VI
VIR-1111
T Cell Immunotherapy
TO
Tobevibart (VIR-3733)
Antiviral Therapy
T
T Cell Platform
Platform Technology
CO
COVID-19 Antibody Program
Antiviral Therapy
Leadership
LP
Louis Picker
Co-Founder
KF
Klaus Frueh
Co-Founder
RN
Robert Nelsen
Co-Founder
SR
Steven Rice
Chief Administrative Officer
Similar companies
Eli Lilly
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
Indianapolis, Indiana
10,001+ employees
Public
Valuation $588B
862 open jobs
Intellia
Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Cambridge, MA
201-500 employees
Public
Valuation $1.2B
3 open jobs
Merck
Global medicines, vaccines, and animal health company
Rahway, New Jersey
10,001+ employees
Public
Valuation $208B
1,462 open jobs
Danaher
American healthcare company
Washington, D.C., United States
10,001+ employees
Public
Valuation $160B
1,992 open jobs
Biogen
American pharmaceutical company
Cambridge, Massachusetts
5,001-10,000 employees
Public
Valuation $16.2B
241 open jobs
Latest updates
All
X
News
HN
YouTube
Analyst Reiterates Buy on Vir Biotechnology, Citing Best-in-Class HDV Profile and Maintaining $18 Price Target - TipRanks
TipRanks
News
·
2 months ago
Vir Biotechnology prices $150M stock offering - MSN
MSN
News
·
2 months ago
Certain Stock options of Vir Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 27-APR-2026. - marketscreener.com
marketscreener.com
News
·
2 months ago
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now? - Yahoo Finance
Yahoo Finance
News
·
2 months ago
Buy Signal Vir Biotechnology Inc - 24 Apr 2026 @ 12:26 -> USD10.21
Ticker: **VIR** Exchange: **NASDAQ** Time: **24 Apr 2026 @ 12:26** Price: **USD10.21** Link: https://getagraph.com/NASDAQ/stock/live-signals/VIR/ENG
·
3 months ago
·
1
Show 15 more
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
3.7
10 reviews
Work-life balance
3.2
Compensation
2.8
Culture
4.1
Career
3.8
Management
3.0
65%
Recommend to a friend
Pros
Supportive and collaborative team culture
Cutting-edge research and meaningful work
Professional development opportunities
Cons
Heavy workload and frequent overtime
Management lacks clear direction and communication
Fast-paced and high-pressure environment
Salary Ranges
22 data points
Junior/L3
Senior/L5
Junior/L3
1 reports
$155,250
total per year
Base
$135,000
Stock
-
$155,250
$155,250
Interview experience
43 interviews
Difficulty
3.3
/ 5
Duration
2-5w
Offer rate
35%
Experience
Positive 63%
Neutral 27%
Negative 10%
Interview process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Contact and location